Targeting Blood Sugar To Near-normal Levels Increases Risk Of Death In Persons With Diabetes At High Risk, ACCORD Trial Shows Jun 7, 2008
6, 2008) Intensively targeting blood sugar to near-normal levels in adults with type 2 diabetes at especially high risk for heart attack and stroke does not significantly reduce the risk of major cardiovascular events, such as fatal or nonfatal heart attacks or stroke, but increases risk of death, compared to standard treatment. Researchers from the ACCORD (Action to Control Cardiovascular Risk in Diabetes) clinical trial compared a medical strategy aimed at near-normal blood sugar levels --... (Science Daily)
O'Ree remains cool-as-ice puck pioneer Mar 2, 2008
The West Coast proved a blessing for O'Ree, who was converted to right wing by the Blades and found that the retinal disorder was much less of a problem as he took to shooting his wrister from the other side. I only played one game against him and he got a goal on me, said Bobby Champoux, a former Gulls goalie who's now a computer analyst at UCSD. He was just so, so quick. (San Diego Union-Tribune -- Sports)
Researchers query FDA about updating requirements for drug approval Feb 1, 2008
The discussion among the 30 participants focused on endpoints and clinical trial strategies for evaluating new treatments for age-related macular degeneration (AMD), diabetic retinopathy and other severe retinal disorders. The exchange is the subject of Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium, an article in the February 2008 issue of ARVOs peer-reviewed journal, Investigative Ophthalmology and Visual Science (). (EurekAlert!)
Advanced Cell wraps up private placement Sep 5, 2007
The company, which uses stem cell technology, is focused on treatments for heart disease and retinal disorders. It has another office in Worcester, Mass. (East Bay Business Times, CA)
Hailing an essential oil Jul 2, 2007
Inflammation exists not only at the core of heart disease, but also neurological conditions, several pain syndromes, retinal disorders and even some forms of cancer. Dr. Eric Shi of the Feinstein Institute for Medical Research in Manhasset is investigating whether omega-3s might play a role in the prevention of breast cancer. (Newsday -- Health)
ThromboGenics Initiates Phase IIb U.S. Clinical Trial of Microplasmin in Vitrectomy Jan 8, 2007
Desire Collen, CEO of ThromboGenics, commenting on today's announcement, said: "Initiation of these two studies before the end of 2006 demonstrates our commitment to advancing microplasmin in the eye field so that we can capture this exciting product's broad potential. The decision to move forward quickly is based on encouraging safety and efficacy results obtained from the Phase IIa trial (MIVI I) which evaluated Microplasmin in vitrectomy in Europe. These results support not only advancement... (PR Newswire)
Pioneers in field of functional genomics work toward gene therapy for vision defects Dec 12, 2006
"We anticipate that our studies of the basic mechanisms controlling gene expression in the retina, and the structure/functional relationships among proteins involved in signal transduction, may lead to development of new methods for early diagnosis of retinal disorders, and ultimately extend our knowledge of the role genes play in construction of the nervous system," she says. . (EurekAlert!)
Sunglasses: A Must Accessory May 7, 2006
People who've had cataract surgery or who have other retinal disorders, and people who take certain medications -- such as tetracycline, sulfa drugs, birth control pills, diuretics, and tranquilizers -- are at increased risk for UV eye damage. Children are more susceptible to UV damage than adults, because they tend to spend more time outdoors. (Health-Finder)
